SEC Comment Letter for PALVELLA THERAPEUTICS, INC. (PVLA) (CIK 0001583648) (PVLA) — Dec 9, 2019
PALVELLA THERAPEUTICS, INC. (PVLA) (CIK 0001583648)
Date: Dec. 9, 2019 · CIK: 0001583648 · Accession: 0000000000-19-016221
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-235350
Letter
December 9, 2019 Ahmed S. Mousa General Counsel PIERIS PHARMACEUTICALS, INC. 255 State Street, 9th Floor Boston, MA 02109 Re:PIERIS PHARMACEUTICALS, INC. Registration Statement on Form S-3 Filed December 4, 2019 File No. 333-235350 Dear Mr. Mousa: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jacqueline Kaufman at 202-551-3797 with any questions. Sincerely, Division of Corporation Finance Office of Trade & Services
Show Raw Text
December 9, 2019
Ahmed S. Mousa
General Counsel
PIERIS PHARMACEUTICALS, INC.
255 State Street, 9th Floor
Boston, MA 02109
Re:PIERIS PHARMACEUTICALS, INC.
Registration Statement on Form S-3
Filed December 4, 2019
File No. 333-235350
Dear Mr. Mousa:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jacqueline Kaufman at 202-551-3797 with any questions.
Sincerely,
Division of Corporation Finance
Office of Trade & Services